In June 2018, FDA (USA’s Food and Drug Administration) has approved the first medicine based on cannabidiol (CBD).
CBD is one of two main metabolites extracted from the cannabis plant. A vast amount of research has proved its many benefits to human health.
Epidiolex will tackle two types of childhood onset epilepsy by significantly reducing the number of seizures patients experience.
Medication offered prior to Epidiolex was not nearly as effective and came with a range of side effects.